These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 35748663

  • 1. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
    Arnaldo P, Mabunda N, Young PW, Tran T, Sitoe N, Chelene I, Nhanombe A, Ismael N, Júnior A, Cubula B, Inlamea OF, Gudo E, Jani IV.
    Clin Infect Dis; 2022 Oct 03; 75(Suppl 2):S285-S293. PubMed ID: 35748663
    [Abstract] [Full Text] [Related]

  • 2. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E, Somi MH, Emami A, Saki N, Hormati A, Ansari-Moghaddam A, Saeedi M, Ghasemi-Kebria F, Mohebbi I, Mansour-Ghanaei F, Karami M, Sharifi H, Pourfarzi F, Veisi N, Ghadimi R, Eghtesad S, Niavarani A, Ali Asgari A, Sadeghi A, Sorouri M, Anushiravani A, Amani M, Kaveh S, Feizesani A, Tabarsi P, Keyvani H, Markarian M, Shafighian F, Sima A, Sadjadi A, Radmard AR, Mokdad AH, Sharafkhah M, Malekzadeh R.
    Lancet Infect Dis; 2021 Apr 03; 21(4):473-481. PubMed ID: 33338441
    [Abstract] [Full Text] [Related]

  • 3. SARS-CoV-2 in Mozambican primary school-aged children at Maputo City and Province: a cross-sectional study from a low-income country.
    Bauhofer AFL, Ussivane É, Chissaque A, Iahaia F, Pololo R, Campos F, Miranda E, António L, Maholela P, Gatambire A, Djedje M, Ráice F, Gonçalves L, de Deus N, Inlamea O.
    BMC Pediatr; 2024 Jul 02; 24(1):425. PubMed ID: 38956534
    [Abstract] [Full Text] [Related]

  • 4. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS, Khan SMS, Qurieshi MA, Majid S, Pandit MI, Haq I, Ahmad J, Bhat AA, Bashir K, Bilquees S, Fazili AB, Hassan M, Jan Y, Kaul RR, Khan ZA, Mushtaq B, Nazir F, Qureshi UA, Raja MW, Rasool M, Asma A, Bhat AA, Chowdri IN, Ismail S, Jeelani A, Kawoosa MF, Khan MA, Khan MS, Kousar R, Lone AA, Nabi S, Qazi TB, Rather RH, Sabah I, Sumji IA.
    Front Public Health; 2022 Jul 02; 10():967447. PubMed ID: 36276377
    [Abstract] [Full Text] [Related]

  • 5. High SARS-CoV-2 Exposure in Rural Southern Mozambique After Four Waves of COVID-19: Community-Based Seroepidemiological Surveys.
    de Jesus Á, Ernesto R, Massinga AJ, Nhacolo F, Munguambe K, Timana A, Nhacolo A, Messa A, Massora S, Escola V, Enosse S, Gunjamo R, Funzamo C, Mwenda JM, Okeibunor J, Garcia-Basteiro A, Guinovart C, Mayor A, Mandomando I.
    Influenza Other Respir Viruses; 2024 Jun 02; 18(6):e13332. PubMed ID: 38838093
    [Abstract] [Full Text] [Related]

  • 6. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS, Wong MCS, Ng RWY, Leung DTM, Chen Z, Lai CKC, Ho WCS, Huang J, Wong BKC, Fung KSC, Chan PKS.
    JAMA Netw Open; 2021 Nov 01; 4(11):e2132923. PubMed ID: 34779848
    [Abstract] [Full Text] [Related]

  • 7. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
    Nkuba AN, Makiala SM, Guichet E, Tshiminyi PM, Bazitama YM, Yambayamba MK, Kazenza BM, Kabeya TM, Matungulu EB, Baketana LK, Mitongo NM, Thaurignac G, Leendertz FH, Vanlerberghe V, Pelloquin R, Etard JF, Maman D, Mbala PK, Ayouba A, Peeters M, Muyembe JT, Delaporte E, Ahuka SM.
    Clin Infect Dis; 2022 Mar 09; 74(5):882-890. PubMed ID: 34089598
    [Abstract] [Full Text] [Related]

  • 8. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, Kumar MS, Rade K, Sabarinathan R, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Khan SMS, Kumar CPG, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk A, Baradwaj DK, Chahal AS, Debnath F, Haq I, Kalliath A, Kanungo S, Kshatri JS, Lakshmi GGJN, Mitra A, Nirmala AR, Prasad GV, Qurieshi MA, Sahay S, Sangwan RK, Sekar K, Shukla VK, Singh PK, Singh P, Singh R, Varma DS, Viramgami A, Panda S, Reddy DCS, Bhargava B, ICMR Serosurveillance Group.
    Lancet Glob Health; 2021 Mar 09; 9(3):e257-e266. PubMed ID: 33515512
    [Abstract] [Full Text] [Related]

  • 9. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
    Palmateer NE, Dickson E, Furrie E, Godber I, Goldberg DJ, Gousias P, Jarvis L, Mathie L, Mavin S, McMenamin J, McNeilly TN, Murcia P, Murray J, Reid G, Robertson C, Templeton K, von Wissmann B, Wallace LA, Waugh C, McAuley A.
    Public Health; 2021 Sep 09; 198():102-105. PubMed ID: 34411992
    [Abstract] [Full Text] [Related]

  • 10. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I, Gonçalves P, Barreto M, Sousa R, Garcia AC, Matos R, Guiomar R, Rodrigues AP, ISNCOVID-19 Group.
    Acta Med Port; 2021 Feb 01; 34(2):87-94. PubMed ID: 33641702
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021).
    Ghosh A, Goyal K, Singh R, Lakshmi PVM, Kaur R, Kumar V, Muralidharan J, Puri GD, Ram J, Singh MP.
    Public Health; 2023 Dec 01; 225():160-167. PubMed ID: 37931485
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon.
    Essomba RG, Bayibeki AN, Lissom A, Ateba PT, Seni N, Fouda CAN, Mbitock SBD, Ebonda ND, Afana SD, Akame S, Tembu AA, Ngamaleu MR, Bimai BCB, Kabo O, Nguwoh PS, Ngounouh CT, Meka MCJ, Kengne M, Likeng JN, Kimessoukie EO, Nkoum BA, Assoumou MCO, Fokam J, Yap Boum II, Ambomo MS, Chadou MJP.
    Influenza Other Respir Viruses; 2023 Nov 01; 17(11):e13222. PubMed ID: 37964992
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C, Sánchez-García A, Rodríguez-Gutiérrez R, Camacho-Ortiz A, Saldívar-Rodríguez D, González-González JG.
    BMC Infect Dis; 2021 Aug 19; 21(1):835. PubMed ID: 34412620
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
    Saeed AY, Assafi MS, Othman HE, Shukri HM.
    J Infect Dev Ctries; 2022 Jul 28; 16(7):1126-1130. PubMed ID: 35905016
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.
    Meireles P, Amaro J, Pinto da Costa J, Lopes MM, Varandas T, Norton P, Guimarães JT, Severo M, Barros H.
    Occup Environ Med; 2021 Sep 28; 78(9):648-653. PubMed ID: 34193594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women.
    González R, Nhampossa T, Figueroa-Romero A, Mendes A, Mazuze M, García-Otero L, Sevene E, Piqueras M, Egri N, Bedini JL, Saúte F, Menendez C.
    J Acquir Immune Defic Syndr; 2023 Feb 01; 92(2):115-121. PubMed ID: 36287578
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
    Javed W, Abidi SHB, Baqar JB.
    BMC Infect Dis; 2022 May 20; 22(1):481. PubMed ID: 35596145
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D, Borré S, Barale A, Isabella A, Milano F, Rossi MA, Silano V, Piu N, Cena T, Faggiano F, Gruppo di Lavoro Fondazione Valsesia.
    Epidemiol Prev; 2020 May 20; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.